chr12-128414823-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001136103.3(TMEM132C):c.177G>T(p.Glu59Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000149 in 1,545,910 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001136103.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMEM132C | NM_001136103.3 | c.177G>T | p.Glu59Asp | missense_variant | 2/9 | ENST00000435159.3 | |
TMEM132C | NM_001387058.1 | c.117G>T | p.Glu39Asp | missense_variant | 2/9 | ||
TMEM132C | XM_047429886.1 | c.177G>T | p.Glu59Asp | missense_variant | 2/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMEM132C | ENST00000435159.3 | c.177G>T | p.Glu59Asp | missense_variant | 2/9 | 5 | NM_001136103.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000178 AC: 27AN: 152098Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000233 AC: 35AN: 150474Hom.: 0 AF XY: 0.000212 AC XY: 17AN XY: 80148
GnomAD4 exome AF: 0.000146 AC: 203AN: 1393812Hom.: 2 Cov.: 30 AF XY: 0.000160 AC XY: 110AN XY: 687704
GnomAD4 genome AF: 0.000178 AC: 27AN: 152098Hom.: 0 Cov.: 32 AF XY: 0.000162 AC XY: 12AN XY: 74300
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2023 | The c.177G>T (p.E59D) alteration is located in exon 2 (coding exon 2) of the TMEM132C gene. This alteration results from a G to T substitution at nucleotide position 177, causing the glutamic acid (E) at amino acid position 59 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at